James F. Reddoch, EVP, Research & Investments at Royalty Pharma plc (RPRX), sold 35,766 shares at $42.01 ($1.5M) on 2021-07-13, disclosed to the SEC on 2021-07-14.
Open-market sale of $1.5M RPRX by EVP, Research & Investments. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.04 | 100 | $4K | 0.3% |
| 2 | $42.01 | 17,832 | $749K | 49.9% |
| 3 | $42.01 | 17,832 | $749K | 49.9% |
| 4 | $42.00 | 2 | $84 | 0.0% |
| Total | $42.01 avg | 35,766 | $1.5M | 100% |
| Filing → |
| RPRX | SELL | 2022-05-31 | $3.1M | — | Filing → |
| RPRX | SELL | 2022-05-23 | $3.0M | — | Filing → |
| RPRX | SELL | 2021-07-27 | $712K | — | Filing → |